Your browser doesn't support javascript.
loading
A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer.
Sternberg, C N; Saad, F; Graff, J N; Peer, A; Vaishampayan, U N; Leung, E; Rosenbaum, E; Gurney, H; Epstein, R J; Davis, I D; Wu, B; Trandafir, L; Wagner, V J; Hussain, M.
Afiliação
  • Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medical Center, New York, USA. Electronic address: cns9006@med.cornell.edu.
  • Saad F; Montreal Cancer Institute, Montreal University Hospital Center (CHUM), Montreal, QC, Canada.
  • Graff JN; Knight Cancer Institute, Oregon Health and Science University and VA Portland Health Care System, Portland, USA.
  • Peer A; Department of Oncology, Rambam Health Care Center, Haifa, Israel.
  • Vaishampayan UN; Department of Oncology, Wayne State University/Karmanos Cancer Institute, Detroit, USA.
  • Leung E; Division of Nuclear Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.
  • Rosenbaum E; Institute of Oncology, Rabin Medical Center-Davidoff Cancer Center, Petah Tikva, Israel.
  • Gurney H; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia.
  • Epstein RJ; Department of Medical Oncology, The Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, Australia.
  • Davis ID; Department of Medicine, Monash University, Melbourne, Australia; Eastern Health, Melbourne, Australia.
  • Wu B; Clinical Statistics Oncology, Bayer HealthCare Pharmaceutical Inc, Whippany, USA.
  • Trandafir L; Global Clinical Development, Bayer Consumer Care AG, Basel, Switzerland.
  • Wagner VJ; Global Clinical Development, Bayer Consumer Care AG, Basel, Switzerland.
  • Hussain M; Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA.
Ann Oncol ; 31(2): 257-265, 2020 02.
Article em En | MEDLINE | ID: mdl-31959342

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Rádio (Elemento) / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials Limite: Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Rádio (Elemento) / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials Limite: Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article